Avelar Rui

CIK 00014320632 companiesVANCOUVER, A1

SEC Profile

Transactions

Companies

Filings

CIK

0001432063

Recent Transactions

35 trades

Sale
Evolus, Inc.$EOLS
Common Stock
2025-05-12$9.87/sh−3,385→ 359,082 total
Sale
Evolus, Inc.$EOLS
Common Stock
2025-03-18$13.26/sh−27,904→ 362,467 total
Award
Evolus, Inc.$EOLS
Performance Restricted Stock Units
2025-03-07+23,776→ 23,776 total
Award
Evolus, Inc.$EOLS
Stock Option (Right to Buy)
2025-03-07+33,875→ 33,875 total
Award
Evolus, Inc.$EOLS
Common Stock
2025-03-07+23,776→ 390,371 total
Sale
Evolus, Inc.$EOLS
Common Stock
2024-12-23$10.85/sh−2,252→ 366,595 total
Sale
Evolus, Inc.$EOLS
Common Stock
2024-05-10$12.72/sh−3,441→ 368,847 total
Sale
Evolus, Inc.$EOLS
Common Stock
2024-03-19$13.92/sh−27,603→ 372,288 total
Sale
Evolus, Inc.$EOLS
Common Stock
2024-02-22$13.08/sh−1,821→ 399,891 total
Award
Evolus, Inc.$EOLS
Common Stock
2024-02-21+13,115→ 401,712 total
Award
Evolus, Inc.$EOLS
Stock Option (Right to Buy)
2024-02-07+47,337→ 47,337 total
Award
Evolus, Inc.$EOLS
Performance Restricted Stock Units
2024-02-07+17,606→ 17,606 total
Award
Evolus, Inc.$EOLS
Common Stock
2024-02-07+35,211→ 388,597 total
Sale
Evolus, Inc.$EOLS
Common Stock
2023-08-16$10.27/sh−2,211→ 353,386 total
Award
Evolus, Inc.$EOLS
Common Stock
2023-08-14+19,672→ 355,597 total
Sale
Evolus, Inc.$EOLS
Common Stock
2023-03-14$8.47/sh−14,906→ 335,925 total
Award
Evolus, Inc.$EOLS
Stock Option (Right to Buy)
2023-01-25+85,670→ 85,670 total
Award
Evolus, Inc.$EOLS
Common Stock
2023-01-25+97,642→ 350,831 total
Sale
Evolus, Inc.$EOLS
Common Stock
2022-03-08$9.73/sh−10,192→ 253,189 total
Award
Evolus, Inc.$EOLS
Common Stock
2022-01-24+53,571→ 263,381 total
Award
Evolus, Inc.$EOLS
Stock Option (Right to Buy)
2022-01-24+77,640→ 77,640 total
Sale
Evolus, Inc.$EOLS
Common Stock
2021-08-10$11.18/sh−14,293→ 209,810 total
Award
Evolus, Inc.$EOLS
Common Stock
2021-01-27+90,000→ 224,103 total
Sale
Evolus, Inc.$EOLS
Common Stock
2021-01-25$7.46/sh−2,699→ 134,103 total
Award
Evolus, Inc.$EOLS
Common Stock
2020-05-13+40,000→ 136,802 total
Award
Evolus, Inc.$EOLS
Common Stock
2020-01-23+26,000→ 96,802 total
Award
Evolus, Inc.$EOLS
Stock Option (Right to Buy)
2020-01-23+45,000→ 45,000 total
Sale
Evolus, Inc.$EOLS
Common Stock
2020-01-07$10.71/sh−39,442→ 70,802 total
Exercise/Conversion
Evolus, Inc.$EOLS
Common Stock
2019-12-10$9.98/sh+10,020→ 110,244 total
Exercise/Conversion
Evolus, Inc.$EOLS
Stock Option (Right to Buy)
2019-12-10−10,020→ 189,682 total
Award
Evolus, Inc.$EOLS
Stock Option (Right to Buy)
2019-01-23+60,000→ 60,000 total
Award
ANGIOTECH PHARMACEUTICALS INC
Stock Option w/Tandem SAR
2010-03-08+135,000→ 790,000 total
Other
ANGIOTECH PHARMACEUTICALS INC
Awards (Options w/Tandem SARs)
2009-06-23−60,000→ 655,000 total
Other
ANGIOTECH PHARMACEUTICALS INC
Options
2009-06-23−200,000→ 715,000 total
Award
ANGIOTECH PHARMACEUTICALS INC
Stock Option w/Tandem SAR
2009-03-10+200,000→ 915,000 total

Companies

Recent Filings

Address

1618 STATION STREET

VANCOUVER, A1, V6A 1B6

View on SEC.gov